G. Pancera

622 total citations
19 papers, 395 citations indexed

About

G. Pancera is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, G. Pancera has authored 19 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in G. Pancera's work include Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (7 papers) and Genetic factors in colorectal cancer (5 papers). G. Pancera is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (7 papers) and Genetic factors in colorectal cancer (5 papers). G. Pancera collaborates with scholars based in Italy. G. Pancera's co-authors include Roberto Labianca, Stefano Cascinu, Sandro Barni, G Luporini, L. Frontini, Giuseppina Catalano, R. Cellerino, Alberto Zaniboni, G. Martignoni and Paolo Giordani and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

G. Pancera

19 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Pancera Italy 9 304 164 96 70 62 19 395
Carla Rabbi Italy 8 168 0.6× 114 0.7× 87 0.9× 39 0.6× 39 0.6× 14 248
N. Vardakis Greece 11 348 1.1× 201 1.2× 64 0.7× 113 1.6× 26 0.4× 35 436
J.F. Seitz France 8 280 0.9× 154 0.9× 91 0.9× 91 1.3× 27 0.4× 29 365
Lawrence P. Leichman United States 11 379 1.2× 239 1.5× 217 2.3× 57 0.8× 115 1.9× 29 563
Eisuke Kaji Japan 10 229 0.8× 261 1.6× 120 1.3× 28 0.4× 157 2.5× 19 468
Bruce Lin United States 10 316 1.0× 146 0.9× 204 2.1× 61 0.9× 40 0.6× 39 397
Katia Dotti Italy 12 364 1.2× 149 0.9× 99 1.0× 56 0.8× 114 1.8× 28 514
G.F. Samelis Greece 10 247 0.8× 159 1.0× 121 1.3× 24 0.3× 16 0.3× 23 372
Friedrich Lang Austria 7 330 1.1× 167 1.0× 161 1.7× 90 1.3× 11 0.2× 10 397
Miaomiao Gou China 13 248 0.8× 124 0.8× 114 1.2× 55 0.8× 40 0.6× 37 352

Countries citing papers authored by G. Pancera

Since Specialization
Citations

This map shows the geographic impact of G. Pancera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Pancera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Pancera more than expected).

Fields of papers citing papers by G. Pancera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Pancera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Pancera. The network helps show where G. Pancera may publish in the future.

Co-authorship network of co-authors of G. Pancera

This figure shows the co-authorship network connecting the top 25 collaborators of G. Pancera. A scholar is included among the top collaborators of G. Pancera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Pancera. G. Pancera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Labianca, Roberto, R. Fossati, Alberto Zaniboni, et al.. (2004). Randomized Trial of Intraportal and/or Systemic Adjuvant Chemotherapy in Patients With Colon Carcinoma. JNCI Journal of the National Cancer Institute. 96(10). 750–758. 21 indexed citations
2.
3.
Cascinu, Stefano, Sandro Barni, Roberto Labianca, et al.. (1999). A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). British Journal of Cancer. 80(10). 1595–1598. 68 indexed citations
4.
Cascinu, Stefano, Giulio Gasparini, Vincenzo Catalano, et al.. (1999). A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Annals of Oncology. 10(11). 1377–1379. 42 indexed citations
5.
Cascinu, Stefano, Roberto Labianca, Sandro Barni, et al.. (1999). Predictors of response to an intensive weekly chemotherapy in advanced gastric cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). CINECA IRIS Institutional Research information system (University of Urbino). 3(1). 79–83. 1 indexed citations
6.
7.
Labianca, Roberto, Stefano Cascinu, L. Frontini, et al.. (1997). High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study. Annals of Oncology. 8(2). 169–174. 20 indexed citations
8.
9.
Pancera, G., et al.. (1997). [Locoregional chemotherapy of liver metastasis from colorectal carcinoma].. PubMed. 67(6). 793–7. 1 indexed citations
10.
Labianca, Roberto, G. Pancera, & G Luporini. (1996). Factors influencing response rates for advanced colorectal cancer chemotherapy. Annals of Oncology. 7(9). 901–906. 8 indexed citations
11.
Labianca, Roberto, Stefano Cascinu, Sandro Barni, et al.. (1995). 735 L-Leucovorin (LLV) as a modulator of 5-days 5-fluorouracil (5FU) in advanced colorectal cancer (ACC): High dose (HD) versus low dose (LD). European Journal of Cancer. 31. S153–S154. 1 indexed citations
12.
Zaniboni, Alberto, Roberto Labianca, G. Pancera, et al.. (1995). Oral Etoposide as Second-Line Chemotherapy for Colorectal Cancer: a GISCAD* Study. Journal of Chemotherapy. 7(3). 246–248. 5 indexed citations
13.
Pancera, G., et al.. (1994). [The evolution of the liver metastases from colorectal carcinoma treated with hepatic intra-arterial chemotherapy. The echographic and CT aspects].. PubMed. 87(6). 796–802. 1 indexed citations
14.
Labianca, Roberto, Sandro Barni, G. Ambrosini, et al.. (1994). Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience. European Journal of Cancer. 30(11). 1611–1616. 8 indexed citations
15.
Rosso, R., Teresita Mazzei, Alberto Sobrero, et al.. (1994). Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma. European Journal of Cancer. 30(3). 338–343. 11 indexed citations
16.
Zee, Benny, Joe Pater, Valter Torri, et al.. (1993). P31 Salvaging clinical trials forced to terminate early by results of external information. Controlled Clinical Trials. 14(5). 439–440. 2 indexed citations
17.
Labianca, Roberto, G. Pancera, Sandro Barni, et al.. (1993). Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer).. PubMed. 339. 233–7. 1 indexed citations
18.
Labianca, Roberto, G. Pancera, Enrico Aitini, et al.. (1991). Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer). Annals of Oncology. 2(9). 673–679. 57 indexed citations
19.
Apolone, Giovanni, Roberto Grilli, A. Alexanian, et al.. (1990). Quality of Care of Colorectal Cancer Patients in General Hospitals: Diffusion and Impact of Management Guidelines. Tumori Journal. 76(3). 261–269. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Rabbi Breakdown of academic impact, for papers by N. Vardakis Breakdown of academic impact, for papers by J.F. Seitz Breakdown of academic impact, for papers by Lawrence P. Leichman Breakdown of academic impact, for papers by Eisuke Kaji Breakdown of academic impact, for papers by Bruce Lin Breakdown of academic impact, for papers by Katia Dotti Breakdown of academic impact, for papers by G.F. Samelis Breakdown of academic impact, for papers by Friedrich Lang Breakdown of academic impact, for papers by Miaomiao Gou
Rankless by CCL
2026